144 related articles for article (PubMed ID: 8882316)
1. Comparative approach to retroviral vaccines.
Burny A
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):389-92. PubMed ID: 8882316
[No Abstract] [Full Text] [Related]
2. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
Biberfeld G; Thorstensson R; Putkonen P
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
[No Abstract] [Full Text] [Related]
3. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
Bhardwaj N; Walker BD
Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
[No Abstract] [Full Text] [Related]
4. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
5. Vaccination against SIV infection and disease.
Gardner MB
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):835-46. PubMed ID: 2167709
[No Abstract] [Full Text] [Related]
6. Roundtable: can experience with veterinary retroviral vaccines be applied to the human situation?
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):365-73. PubMed ID: 8882312
[No Abstract] [Full Text] [Related]
7. Vaccination against HIV and SIV.
Leclerc C
Curr Opin Immunol; 1989-1990 Feb; 2(3):428-32. PubMed ID: 2483885
[No Abstract] [Full Text] [Related]
8. Cellular and molecular mechanisms of vaccine-induced protection against retroviral infections.
Dittmer U; Hasenkrug KJ
Curr Mol Med; 2001 Sep; 1(4):431-6. PubMed ID: 11899087
[TBL] [Abstract][Full Text] [Related]
9. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
10. Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus.
Joag SV; Li Z; Wang C; Foresman L; Jia F; Stephens EB; Zhuge W; Narayan O
AIDS Res Hum Retroviruses; 1999 Mar; 15(4):391-4. PubMed ID: 10082123
[TBL] [Abstract][Full Text] [Related]
11. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
12. The relevance of feline retroviruses to the development of vaccines against HIV.
Jarrett O
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):385-7. PubMed ID: 8882315
[No Abstract] [Full Text] [Related]
13. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines.
Dittmer U; Hasenkrug KJ
AIDS Res Hum Retroviruses; 1999 May; 15(8):785. PubMed ID: 10357475
[No Abstract] [Full Text] [Related]
14. Why do we not have an HIV vaccine and how can we make one?
Burton DR; Moore JP
Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194
[No Abstract] [Full Text] [Related]
15. HIV vaccines--where are we going?
Heilman CA; Baltimore D
Nat Med; 1998 May; 4(5 Suppl):532-4. PubMed ID: 9585205
[No Abstract] [Full Text] [Related]
16. Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies.
Daniel MD; Desrosiers RC
AIDS; 1989; 3 Suppl 1():S131-3. PubMed ID: 2558686
[No Abstract] [Full Text] [Related]
17. Are we detouring from a direct route to development of HIV vaccines?
Fultz PN
Vaccine; 1991 Nov; 9(11):783-7. PubMed ID: 1759499
[TBL] [Abstract][Full Text] [Related]
18. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
19. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
20. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
